A list of hematology clinical practice guidelines from ASH and from other organizations.

Intravenous immunoglobulin, accessory splenectomy, high-dose steroids, androgens, and immunosuppression - these were the recommendations made by the ASH ITP practice guidelines for adult patients with refractory ITP (George, et al. Blood, 1996).

Today’s Education Session on Thrombocytopenia (7:30 – 9:00 a.m. and 2:00 – 3:30 p.m.) features updates on management of ITP, HIT, and TTP, including the exciting new thrombopoietin agents that enhance platelet counts in antibody-mediated thrombocytopenia.

March 2008 Practice Update (part one)

Measure 1 The patient s baseline diagnostic evaluation includes review of a peripheral blood smear Numerator The number of patients in your selection with ITP ICD-9 code 287.3X with exclusions as above AND Including review of a peripheral blood smear as part of baseline diagnostic evaluation Peripheral

 A PDF of the May-June 2007 issue of The Hematologist.

2010 Abstract Review Categories

2009 Abstract Review Categories Red Cell Physiology and Disorders Abstracts submitted to categories 101-112 will generally exclude studies of transplantation for red cell disorders and anemias, regardless of cause (see categories 721 or 722). Studies of erythroid differentiation and erythropoiesis should be submitted t

In late January 2010, ASH moved to its new headquarters building at 2021 L Street, NW, in downtown Washington, DC. It was purchased by ASH in late 2008. The 10-story, 80,000 square foot building will house our 65-person headquarters staff, accommodate ASH committee meetings in its top floor conference center, and be ho

The following goal-oriented Hematology curriculum recommendations attempt to incorporate specific areas of content with the expectation of competency for subspecialty training. We have carefully and intentionally chosen the phrases that begin each knowledge or skill description in an attempt to emphasize the priority that we believe is appropriate for that topic area. This framework is also expected to contribute to the development of education materials for use by all physicians interested in Hematology and to identify areas that can interact with, and can take advantage of, ASH educational resources.

Data that shed new light on the treatment of residual vein thrombosis, thromboprophylaxis after total hip replacement, chronic immune thrombocytopenic purpura, and venous thrombosis in relation to postmenopausal hormone replacement therapy will be presented at the 49th Annual Meeting of the American Society of Hematology in Atlanta, GA.

A PDF of the January-February 2008 issue of The Hematologist. 

 A PDF of the September-October 2006 issue of The Hematologist.